Mersana Therapeutics

World Rank (Jan-05-2024)

16,205

Market Cap (Jan-05-2024)

0.279 Billion USD

World Rank (Jul-30-2023)

19,774

Market Cap (Jul-30-2023)

0.144 Billion USD

World Rank (Jan-07-2022)

14,071

Market Cap (Jan-07-2022)

0.451 Billion USD

World Rank (Jan-01-2021)

5,781

Market Cap (Jan-01-2021)

1.823 Billion USD

Headquarters Country

USA

Nasdaq / NYSE Code

MRSN

Employee Count

169

Employee Count as of Date

As on 2021

Headquarters City/State

Massachusetts

World Region

Americas

World Subregion

Northern America

Annual Revenue in USD

1 Million USD

Annual Results for Period Ending

Dec-2020 ending year

Balance Sheet for Period Ending

Dec-2020 ending year

Business Sector

Company Website

Yahoo

Company Profile

Mersana Therapeutics is a Biopharmaceutical company specializing in the discovery and development of antibody drug conjugate (ADC) therapies to treat patients fighting cancer. The company total assets is 107.5 million USD as on 2019, total liabilities is 29.2 million USD as on 2019, annual revenue is 42.1 million USD as on 2019 and total equity is 78.3 million USD as on 2019.The headquarters is in USA.

Founded Year

2001

IPO Year

2017

Stock Exchange

Nasdaq

Nasdaq Sector

Health Care

Nasdaq Industry

Biotechnology: Pharmaceutical Preparations